Expression Behavior of 85‐kDa Membrane Protein in Adriamycin‐resistant Tumor Cells and the Inhibition of Human Tumor Growth in Athymic Mice by MRK‐20 Monoclonal Antibody against the Protein

Treatment of tumors with monoclonal antibodies against tumor antigen is one of the selective modalities for cancer therapy. We examined the therapeutic effect of MRK‐20 (IgG(1)), a murine monoclonal antibody against resistance‐associated 85‐kDa membrane protein. The 85‐kDa protein is expressed on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Shigetaka, Naito, Mikihiko, Tsuruo, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1993
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919210/
https://www.ncbi.nlm.nih.gov/pubmed/8370652
http://dx.doi.org/10.1111/j.1349-7006.1993.tb02043.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919210/
https://www.ncbi.nlm.nih.gov/pubmed/8370652
http://dx.doi.org/10.1111/j.1349-7006.1993.tb02043.x

Ejemplares similares